Find clinical trials for Triple Negative Breast Cancer in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Philadelphia, PA, USA:
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative b ...
Phase 2
Philadelphia, Pennsylvania, United States and 9 other locations
This randomized phase II trial studies how well carboplatin with or without atezolizumab works in treating patients with stage IV triple negative...
Phase 2
Philadelphia, Pennsylvania, United States and 5 other locations
The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer...
Phase 2
Philadelphia, Pennsylvania, United States and 8 other locations
the feasibility of 1 year of adjuvant enzalutamide, an androgen receptor (AR) antagonist for the treatment of patients with early stage, AR(+) triple...
Phase 2
Allentown, Pennsylvania, United States and 11 other locations
This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...
Phase 1, Phase 2
Newark, Delaware, United States and 49 other locations
avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...
Phase 2
Philadelphia, Pennsylvania, United States and 11 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Philadelphia, Pennsylvania, United States and 165 other locations
This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...
Phase 3
Philadelphia, Pennsylvania, United States and 199 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Philadelphia, Pennsylvania, United States and 516 other locations
CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small...
Phase 1
Philadelphia, Pennsylvania, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal